Re: Health Canada Issues Resverlogix Authorization to Begin Immediate Clinical Studies of Apabetalone for COVID-19
posted on
Apr 12, 2021 08:39AM
What we really need here is a significantly successful trial. That is key. Then for sure you will get the positive exposure the company needs.